trog small copyGenesis CancerCare and Trans-Tasman Radiation Oncology Group Strategic Partnership

The Trans-Tasman Radiation Oncology Group (TROG) is a global leader in radiotherapy research working with over nine hundred researchers and doctors in more than 50 trials involving over 12,000 patient volunteers to help advance cancer treatments. GenesisCare is the leading provider of radiation oncology in Australia undertaking around 320,000 cancer treatments every year and is currently involved in over 40 clinical trials.

Genesis CancerCare and TROG will work together to improve patient access to clinical trials and promote innovation in research to deliver better patient outcomes.

Follow us on Facebook

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and cardiovascular disease - in an environment of substantial unmet demand from an ageing population. Click here to learn more